Approval · Notice of Compliance 8923 · 2007
ALVESCO: Notice of Compliance 8923
Issued July 20, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8923
- Date
- July 20, 2007
- Company
- Altana Pharma Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Extended indication: prophylactic management of steroid-responsive bronchial asthma in adolescents 12 years of age and older and other revisions to the product monograph
- Therapeutic class
- Corticosteroid for oral inhalation
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALVESCO | Not yet assigned | — |
Medicinal ingredients
- CICLESONIDE 50 MCG per ACT
- CICLESONIDE 100 MCG per ACT
- CICLESONIDE 200 MCG per ACT